Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography

被引:99
作者
Davies, Douglas R. [1 ]
Mamat, Bjorn [2 ]
Magnusson, Olafur T.
Christensen, Jeff [1 ]
Haraldsson, Magnus H. [3 ]
Mishra, Rama [2 ]
Pease, Brian [2 ]
Hansen, Erik [1 ]
Singh, Jasbir [2 ]
Zembower, David [2 ]
Kim, Hidong [1 ]
Kisclyov, Alex S. [2 ]
Burgin, Alex B. [1 ]
Gurney, Mark E. [3 ]
Stewart, Lance J. [1 ]
机构
[1] DeCODE Biostruct Inc, Bainbridge Isl, WA 98110 USA
[2] DeCODE Chem Inc, Woodridge, IL 60517 USA
[3] DeCODE Genet Inc, IS-101 Reykjavik, Iceland
关键词
PROTEIN-PROTEIN INTERACTIONS; ALPHA-HELIX MIMETICS; A(4) HYDROLASE; X-RAY; POTENT INHIBITORS; LEAD DISCOVERY; B-4; RECEPTOR; ANTIINFLAMMATORY ACTIVITY; SACCHAROMYCES-CEREVISIAE; INTERMEDIARY METABOLISM;
D O I
10.1021/jm900259h
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We describe a novel fragment library termed fragments of life (FOL) for structure-based drug discovery. The FOL library includes natural small molecules of life, derivatives thereof, and biaryl protein architecture mimetics. The choice of fragments facilitates the interrogation of protein active sites, allosteric binding sites, and protein-protein interaction surfaces for fragment binding. We screened the FOL library against leukotriene A4 hydrolase (LTA4H) by X-ray crystallography. A diverse set of fragments including derivatives of resveratrol, nicotinamide, and indole were identified as efficient ligands for LTA4H. These fragments were elaborated in a small number of synthetic cycles into potent inhibitors of LTA4H representing multiple novel chemotypes for modulating leukotriene biosynthesis. Analysis of the fragment-bound structures also showed that the fragments comprehensively recapitulated key chemical features and binding modes of several reported LTA4H inhibitors.
引用
收藏
页码:4694 / 4715
页数:22
相关论文
共 98 条
[41]   The maximal affinity of ligands [J].
Kuntz, ID ;
Chen, K ;
Sharp, KA ;
Kollman, PA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (18) :9997-10002
[42]   Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates [J].
Kwong, PD ;
Wyatt, R ;
Majeed, S ;
Robinson, J ;
Sweet, RW ;
Sodroski, J ;
Hendrickson, WA .
STRUCTURE, 2000, 8 (12) :1329-1339
[43]   Sirtuins - novel therapeutic targets to treat age-associated diseases [J].
Lavu, Siva ;
Boss, Olivier ;
Elliott, Peter J. ;
Lambert, Philip D. .
NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (10) :841-853
[44]   SAR and X-ray.: A new approach combining fragment-based screening and rational drug design:: Application to the discovery of nanomolar inhibitors of Src SH2 [J].
Lesuisse, D ;
Lange, G ;
Deprez, P ;
Bénard, D ;
Schoot, B ;
Delettre, G ;
Marquette, JP ;
Broto, P ;
Jean-Baptiste, V ;
Bichet, P ;
Sarubbi, E ;
Mandine, E .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (12) :2379-2387
[45]   Structural diversity of organic chemistry. A scaffold analysis of the CAS Registry [J].
Lipkus, Alan H. ;
Yuan, Qiong ;
Lucas, Karen A. ;
Funk, Susan A. ;
Bartelt, William F., III ;
Schenck, Roger J. ;
Trippe, Anthony J. .
JOURNAL OF ORGANIC CHEMISTRY, 2008, 73 (12) :4443-4451
[46]  
Llorca J, 2004, INT MICROBIOL, V7, P239
[47]   Leukotriene B4 receptors BLT1 and BLT2:: Expression and function in human and murine mast cells [J].
Lundeen, Katherine A. ;
Sun, Binggang ;
Karlsson, Lars ;
Fourie, Anne M. .
JOURNAL OF IMMUNOLOGY, 2006, 177 (05) :3439-3447
[48]   Inositol hexakisphosphate is bound in the ADAR2 core and required for RNA editing [J].
Macbeth, MR ;
Schubert, HL ;
VanDemark, AP ;
Lingam, AT ;
Hill, CP ;
Bass, BL .
SCIENCE, 2005, 309 (5740) :1534-1539
[49]   On sampling of fragment space [J].
Makara, Gergely M. .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (14) :3214-3221
[50]   A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening [J].
McGovern, SL ;
Caselli, E ;
Grigorieff, N ;
Shoichet, BK .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (08) :1712-1722